Unit 11 Drug Resistance and MDR-TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.

Slides:



Advertisements
Similar presentations
Dr. Essam El Moghazy NTP Egypt
Advertisements

Evaluation Questions Note: If not used for testing purposes, evaluation questions may be used in slide format inserted within or at the end of each module.
ISTC Training Modules 2008 Your name Institution/organization Meeting Date.
Your name Institution/organization Meeting Date. Introduction.
Module 7: Patient Education. Learning Objectives Explain the importance of patient education during the TB treatment process Describe the District TB.
June 2004 HITCH Training Slide Set #3 Special Considerations in Antiretroviral Therapy.
TREATMENT OF TUBERCULOSIS, 2003
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
Unit 8: Complications and Special Situations Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Module 9 Part A: Monitoring and Evaluation *Image courtesy of: World Lung Foundation.
Clinical Case Female, 27 years of age 3 rd year Internal Medicine resident at the Mexicali General Hospital Never smoked; does not ingest alcoholic beverages.
Group II Treatment regimens, hospitalization. DOT provision, outcome definitions, management of adverse drug reactions.
Efficacy and Safety of a 4-Drug Fixed- Dose Combination Regimen Compared With Separate Drugs for Treatment of Pulmonary Tuberculosis The Study C Randomized.
7. Anti-TB regimen in special situations of liver disease, renal impairment, and pregnancy.
Module 3: Drug-Resistant TB. Learning Objectives Describe how drug resistance emerges Explain the difference between primary and secondary resistance.
KEY CHANGES IN THE NEW NTBLCP GUIDELINES
Unit 10 Treating the Dually Infected Patient: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
TB. Areas of Concern TB cases continue to be reported in every state Drug-resistant cases reported in almost every state Estimated million persons.
HIV-TB Model: The Botswana experience By E.M. Lungu (UB) M. Kgosimore (BCA) F. Nyabadza (UB) Modeling Disease in Africa Workshop 25 – 27 June 2007, Stellenbosch,
Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.
Diagnosis of TB.
Unit 5: IPT Isoniazid TB Preventive Therapy
4 th National Anti-tuberculosis Drug Resistance Survey Botswana, 2007.
Plans for Diagnosis and Management of Acute Pyelonephritis.
TUBERCULOSIS Diagnosis & treatment
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
Unit 9 Diagnosis and Treatment of Paediatric TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Unit 7 Treatment of TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Unit 6 Diagnosing TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Extrapulmonary Site 2 :_____________________ Name (surname, first name) Age (in years) Sex F Alternative address Physical Address (in full) M INTERIM TUBERCULOSIS.
Tuberculosis Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Tuberculosis (TB) The incidence of.
TB 101 Part II Brenda Mayes, R. N. March TREATMENT TB DISEASE MDR XDR LATENT TB INFECTION.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Progress of the Singapore TB Elimination Programme (STEP)
V IRGINIA C OHORT D ATA – 5 YEAR TRENDS AFTER 4 YEARS OF LOCAL COHORT REVIEW Virginia achievement on National TB Indicators for the past 5 years – where.
TB/HIV management survey  Baseline audit in parallel with guidelines development process  Survey of clinician opinion and practice  Data collection.
Unit 12: Reporting & Recording Botswana National Tuberculosis Programme Manual Training for Medical Officers.
DOTS-PLUS IN TANZANIA: PREPARATION PHASE Global DOTS Expansion Working Group Meeting, Paris: 28 October 2004 NTLP - MOH Prepared by: Dr. S. M. Egwaga NTLP.
1 Monitoring The Patient on ARV Treatment HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Revising the WHO TB Treatment Guidelines Process and new recommendations Malgosia Grzemska Matteo Zignol Stop TB Department World Health Organization DEWG.
By: Michelle Russell.  To become familiar with the disease process of TB Transmission symptoms Precautions  Nursing Diagnoses  Interventions.
Extrapulmonary Site 2 :_____________________ TUBERCULOSIS TREATMENT CARD BOTSWANA NATIONAL TUBERCULOSIS PROGRAMME Date RegisteredIN ToOUT RegisteredIN.
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 7: GAP BETWEEN AVAILABILTY OF DRUG SUSCEPTIBILITY.
Tuberculosis control in Suriname Situational analysis.
Unit 5 Isoniazid Prevention Therapy: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Clinical Case Female, 27 years of age Female, 27 years of age 3 rd year Internal Medicine resident at the Mexicali General Hospital 3 rd year Internal.
SA TB Guidelines – The interface with Advanced Clinical Care Dr Kogie Naidoo Head: CAPRISA Treatment Research Programme Annual Workshop on Advanced Clinical.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
EBM Appraisal (Diagnostics). Clinical Scenario You are the duty resident at the traige on a Sunday afternoon when... a 3 year old Male came with a chief.
LEARNING MODULE TITLE SUBTITLE. HISTORY OF PRESENT ILLNESS An 18 year-old woman with no past medical history and no known risks for TB presents with several.
Unit 1: Course Introduction Botswana National Tuberculosis Programme Manual Training for Medical Officers.
TREATMENT of TB in ADULTS
Treatment Regimens for Pulmonary Tuberculosis Caused by Drug- Susceptible Organisms Initial PhaseContinuation Phase RegimenDrugs Interval and Doses (Minimal.
Roundtable. Detection and treatment of TB Andrew Black.
Tuberculosis in Children: Treatment and Monitoring Module 10B - March 2010.
Communicating with Patients and Providers HIV Care and ART: A Course for Pharmacists.
Case Holding (TB-DOTS Training). Case holding a set of procedures which ensures that patients complete their treatment involves assignment of the appropriate.
EPIDEMIOLOGY OF PULMONARY TUBERCULOSIS. LEARNIN G OBJECTIVES State the diagnostic criteria of pulmonary tuberculosis Describe trend & state reasons for.
Antituberculous treatment.
US TB Treatment Guidelines and DOT
Management of the Newborn When Maternal TB Suspected
This is an archived document.
Module 4: Role Playing and Case Discussions
Dr Dawood Quiz questions.
Epidemiology of pulmonary tuberculosis
Using Mobile Phones to Monitor and
Tuberculosis in children BY MBBSPPT.COM
Treatment of Drug Resistant TB - Questions
Presentation transcript:

Unit 11 Drug Resistance and MDR-TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers

Slide 2 Unit 11: Case Studies B Family Case 2-4 weeks after re-starting anti-tuberculosis drugs, Mr. B begins taking: Alluvia, 2 tabs BD Ritonavir, 3 capsules BD Combivir, 1 tab BD Mr. B does well on his new ART regimen and returns to the clinic 3 months later to submit his sputum specimens at completion of the intensive phase

Slide 3 Unit 11: Case Studies B Family Case: Question 1 1.How many samples do you collect? 2.Do you order a culture?

Slide 4 Unit 11: Case Studies B Family Case: Answer samples for microscopy 2.1 sample for culture, since he is a retreatment case

Slide 5 Unit 11: Case Studies Case B Family : Question 2 Both sputum microscopy are negative Culture comes back negative 1.How do you manage Mr. B now? 2.Is he cured?

Slide 6 Unit 11: Case Studies B Family Case: Answer 2 1.Continue with continuation phase of Category II HRE x 5 months 2.Mr. B is only considered cured if you obtain sputum at completion of treatment and it is negative for AFB

Slide 7 Unit 11: Case Studies B Family Case: Additional Information At completion of treatment, 2 sputum specimens are obtained for AFB They both return negative Mr. B completes ATT and continues with his ART

Unit 11 Drug Resistance and MDR-TB: Additional Case Botswana National Tuberculosis Programme Manual Training for Medical Officers

Slide 9 Unit 11: Case Studies Additional Case A 44 year old woman named Margaret Complaint of cough for more than 4 weeks, fever and weight loss Had been on Category I tuberculosis treatment last year x 3 months, but did not return to pick up medications thereafter TB was diagnosed at that time with 2 sputum smears positive for AFB At that time, her family said she had moved but did not know where

Slide 10 Unit 11: Case Studies Additional Case: Question 1 Wt 48kg Temperature 38 Respirations 22 Heart Rate 92 Physical exam normal except for generalized lymphadenopathy What is her TB diagnostic classification and why?

Slide 11 Unit 11: Case Studies Additional Case: Answer 1 TB diagnostic classification: Defaulter TB treatment interrupted Margaret discontinued treatment for more than 10 weeks

Slide 12 Unit 11: Case Studies Additional Case: Questions 2 1.What is your management plan? 2.What TB drugs do you put her on? 3.What else, besides medication, do you address now?

Slide 13 Unit 11: Case Studies Additional Case: Answers 2 1.Management Send sputum for culture and DST HIV test Explore reasons for previous non-adherence and develop plan to prevent non-adherence during this treatment episode Ensure DOT Offer an HIV test and ask why or decipher why she defaulted Address nutrition 2.TB treatment: Category II Intensive phase - DOT HRZES daily for first 2 months HRZE daily for 1 month If MDR-TB found on culture and sensitivity, refer to specialist 3.Address social situation, laboratory evaluation, etc.

Slide 14 Unit 11: Case Studies Additional Case: Question 3 What are the criteria for her to complete the initial phase of treatment and move on to the continuation phase?

Slide 15 Unit 11: Case Studies Additional Case: Answer 3 In order to complete the initial phase of treatment, she must: Adhere for 3 months Show clinical improvement No fever Cough improves Gains weight Have negative sputum smears at 3 months

Slide 16 Unit 11: Case Studies Additional Case: Question 4 Cough improved 1 kg weight gain Sputum smear positive (1+) DST results from sputum sent for culture at initiation are still not back What do you do now?

Slide 17 Unit 11: Case Studies Additional Case: Answer 4 Continue HRZE for fourth month Assess adherence Reinforce need to avoid missing doses if that is happening Enlist family support for her Assess clinical status, i.e., weight gain, cough, fever, at each visit Repeat smear at end of the fourth month

Slide 18 Unit 11: Case Studies Additional Case: Questions 5 DST results from the initial culture are now available Resistance to Isoniazid and Rifampicin found Streptomycin and Ethambutol susceptible 1.What do you do now? 2.What drug regimen do you recommend?

Slide 19 Unit 11: Case Studies Additional Case: Answers 5 1.Refer Margaret to specialist 2.Drug Regimen (table 7.3 in BNTP manual) Pyrazinamide Ethionamide Ciprofloxacin Amykacin Ethambutol